[Usefulness for differential diagnosis of the distribution of extrapyramidal symptoms resulting from neuroleptic therapy in psychiatric practice].
During the neuroleptic treatment of 100 schizophrenic and cyclophrenic patients, respectively, the developing extrapyramidal symptoms were found to reveal a peculiar single-sided overweight: in the case of schizophrenics on the right, whereas in maniacdepression cases on the left side. This lateral difference was maintained even at temporary different syndromatics in the course of the disease. All these raise the idea of applying the so-called Haloperidol test when differential diagnostically difficult cases, decided upon rather only on the basis of the longitudinal section are encountered. The single-sided overweight of the extrapyramidal symptoms developed have clearly indicated both initially and subsequently the diagnosis confirmed later on.
D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D001714:Bipolar Disorder / Q000175:diagnosis*; D003937:Diagnosis, Differential; D005260:Female; D007839:Functional Laterality; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D012559:Schizophrenia / Q000175:diagnosis*; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000627:therapeutic use*
D014149:Tranquilizing Agents; D006220:Haloperidol
Die differentialdiagnostische Nutzbarkeit der Verteilung der extrapyramidalen Symptome infolge der neuroleptischen Therapie in der psychiatrischen Praxis